Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
July 28, 2025
Accession Number:
0001193125-25-165532
Submission Type:
POS AM
CIK:
0001840574
Company Name:
Verve Therapeutics, Inc.
File Number:
333-267578